Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
158.73
-4.33 (-2.66%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Belite Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 352.93 | 31.68 | 88.16 | 42.09 | 17.34 | Upgrade
|
| Short-Term Investments | 139.49 | 113.47 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 492.42 | 145.15 | 88.16 | 42.09 | 17.34 | Upgrade
|
| Cash Growth | 239.25% | 64.65% | 109.45% | 142.67% | -32.30% | Upgrade
|
| Other Receivables | 0.7 | 0.58 | 0.84 | 0 | - | Upgrade
|
| Receivables | 0.7 | 0.58 | 0.84 | 0 | - | Upgrade
|
| Prepaid Expenses | 1.13 | 1.33 | 0.92 | 0.7 | 0.06 | Upgrade
|
| Other Current Assets | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | Upgrade
|
| Total Current Assets | 494.27 | 147.07 | 89.94 | 42.81 | 17.43 | Upgrade
|
| Property, Plant & Equipment | 0.78 | 0.97 | 1.3 | 1.35 | 0.09 | Upgrade
|
| Long-Term Investments | 280.17 | - | - | - | - | Upgrade
|
| Other Intangible Assets | 0.02 | 0.03 | - | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0.82 | Upgrade
|
| Other Long-Term Assets | 5.32 | 4.06 | 3.4 | 0.12 | 0.01 | Upgrade
|
| Total Assets | 780.56 | 152.13 | 94.64 | 44.27 | 18.35 | Upgrade
|
| Accrued Expenses | 7.31 | 4.86 | 3.18 | 1.83 | 1.54 | Upgrade
|
| Current Portion of Leases | 0.24 | 0.28 | 0.31 | 0.2 | - | Upgrade
|
| Other Current Liabilities | 2.33 | 0.92 | 0.15 | 0.07 | 0.1 | Upgrade
|
| Total Current Liabilities | 9.88 | 6.05 | 3.63 | 2.1 | 1.64 | Upgrade
|
| Long-Term Leases | 0.19 | 0.26 | 0.58 | 0.67 | - | Upgrade
|
| Total Liabilities | 10.07 | 6.31 | 4.21 | 2.77 | 1.64 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 956.28 | 254.13 | 162.31 | 81.76 | 12.33 | Upgrade
|
| Retained Earnings | -185.26 | -107.65 | -71.5 | -39.87 | -27.22 | Upgrade
|
| Comprehensive Income & Other | -0.54 | -0.66 | -0.37 | -0.39 | -0.2 | Upgrade
|
| Total Common Equity | 770.49 | 145.82 | 90.43 | 41.5 | -15.09 | Upgrade
|
| Shareholders' Equity | 770.49 | 145.82 | 90.43 | 41.5 | 16.71 | Upgrade
|
| Total Liabilities & Equity | 780.56 | 152.13 | 94.64 | 44.27 | 18.35 | Upgrade
|
| Total Debt | 0.43 | 0.54 | 0.89 | 0.87 | - | Upgrade
|
| Net Cash (Debt) | 491.99 | 144.61 | 87.27 | 41.22 | 17.34 | Upgrade
|
| Net Cash Growth | 240.22% | 65.70% | 111.71% | 137.68% | -32.30% | Upgrade
|
| Net Cash Per Share | 14.67 | 4.74 | 3.28 | 2.06 | 1.81 | Upgrade
|
| Filing Date Shares Outstanding | 39.34 | 31.83 | 29.15 | 24.9 | 10.27 | Upgrade
|
| Total Common Shares Outstanding | 39.34 | 31.83 | 29.15 | 24.9 | 10.27 | Upgrade
|
| Working Capital | 484.39 | 141.02 | 86.31 | 40.7 | 15.8 | Upgrade
|
| Book Value Per Share | 19.59 | 4.58 | 3.10 | 1.67 | -1.47 | Upgrade
|
| Tangible Book Value | 770.47 | 145.79 | 90.43 | 41.5 | -15.09 | Upgrade
|
| Tangible Book Value Per Share | 19.58 | 4.58 | 3.10 | 1.67 | -1.47 | Upgrade
|
| Machinery | 0.66 | 0.6 | 0.49 | 0.45 | 0.14 | Upgrade
|
| Leasehold Improvements | 0.19 | 0.19 | 0.19 | 0.19 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.